Advertisement
Canada markets open in 2 hours 33 minutes
  • S&P/TSX

    21,714.54
    -297.08 (-1.35%)
     
  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • CAD/USD

    0.7261
    0.0000 (-0.00%)
     
  • CRUDE OIL

    80.73
    -1.20 (-1.46%)
     
  • Bitcoin CAD

    79,341.48
    -5,591.71 (-6.58%)
     
  • CMC Crypto 200

    1,235.91
    -103.15 (-7.70%)
     
  • GOLD FUTURES

    2,302.30
    -0.60 (-0.03%)
     
  • RUSSELL 2000

    1,973.91
    -42.12 (-2.09%)
     
  • 10-Yr Bond

    4.6860
    +0.0720 (+1.56%)
     
  • NASDAQ futures

    17,446.25
    -125.00 (-0.71%)
     
  • VOLATILITY

    16.13
    +0.48 (+3.07%)
     
  • FTSE

    8,143.07
    -1.06 (-0.01%)
     
  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     
  • CAD/EUR

    0.6803
    +0.0001 (+0.01%)
     

H.B. Fuller First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

H.B. Fuller (NYSE:FUL) First Quarter 2024 Results

Key Financial Results

  • Revenue: US$810.4m (flat on 1Q 2023).

  • Net income: US$31.0m (up 42% from 1Q 2023).

  • Profit margin: 3.8% (up from 2.7% in 1Q 2023).

  • EPS: US$0.57 (up from US$0.40 in 1Q 2023).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

H.B. Fuller EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) exceeded analyst estimates by 5.0%.

Looking ahead, revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in the US.

ADVERTISEMENT

Performance of the American Chemicals industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for H.B. Fuller that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.